Literature DB >> 116808

Pathologic classification of meibomian gland carcinomas of eyelids: clinical and pathologic study of 156 cases.

C Ni, B K Guo.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 116808

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  7 in total

1.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.

Authors:  S Kaliki; A Ayyar; T V Dave; M J Ali; D K Mishra; M N Naik
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

2.  E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.

Authors:  Liang Li; Zhe Zhang; Bin Li; Fei Gao; Liaoqing Li; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-08       Impact factor: 3.117

3.  Neoadjuvant Systemic Chemotherapy in Sebaceous Gland Carcinoma of the Eyelid: A Retrospective Study.

Authors:  Saurav Verma; Nipun Kumar; Rachna Meel; Seema Sen; Seema Kashyap; Sanjay Sharma; Neelam Pushker; Deepam Pushpam; Sameer Bakhshi
Journal:  Ocul Oncol Pathol       Date:  2021-05-05

4.  Sebaceous Gland Carcinoma of Eyelid- A Tarnished Masquerade.

Authors:  Bijnya Birajita Panda; Sucheta Parija; Susanta Pujahari; Jyotiranjan Mallick
Journal:  J Clin Diagn Res       Date:  2016-04-01

5.  Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.

Authors:  Swathi Kaliki; Adit Gupta; Mohammed Hasnat Ali; Anuradha Ayyar; Milind N Naik
Journal:  Int Ophthalmol       Date:  2016-02-01       Impact factor: 2.031

6.  Periocular sebaceous gland carcinoma: A comprehensive review.

Authors:  Kaustubh Mulay; Ekta Aggarwal; Valerie A White
Journal:  Saudi J Ophthalmol       Date:  2013-07

7.  Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome.

Authors:  Syed Ali Raza Rizvi; Md Shahid Alam; Kafil Akhtar
Journal:  Oman J Ophthalmol       Date:  2018 Jan-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.